Literature DB >> 20729806

Transurethral induction of mouse urinary tract infection.

Kim H Thai1, Anuradha Thathireddy, Michael H Hsieh.   

Abstract

Uropathogenic bacterial strains of interest are grown on agar. Generally, uropathogenic E. coli (UPEC) and other strains can be grown overnight on Luria-Bertani (LB) agar at 37 degrees C in ambient air. UPEC strains grow as yellowish-white translucent colonies on LB agar. Following confirmation of appropriate colony morphology, single colonies are then picked to be cultured in broth. LB broth can be used for most uropathogenic bacterial strains. Two serial, overnight LB broth cultures can be employed to enhance expression of type I pili, a well-defined virulence factor for uropathogenic bacteria. Broth cultures are diluted to the desired concentration in phosphate buffered saline (PBS). Eight to 12 week old female mice are placed under isoflurane anesthesia and transurethrally inoculated with bacteria using polyethylene tubing-covered 30 gauge syringes. Typical inocula, which must be empirically determined for each bacterial/mouse strain combination, are 10(6) to 10(8) cfu per mouse in 10 to 50 microliters of PBS. After the desired infection period (one day to several weeks), urine samples and the bladder and both kidneys are harvested. Each organ is minced, placed in PBS, and homogenized in a Blue Bullet homogenizer. Urine and tissue homogenates are serially diluted in PBS and cultured on appropriate agar. The following day, colony forming units are counted.

Entities:  

Mesh:

Year:  2010        PMID: 20729806      PMCID: PMC3156012          DOI: 10.3791/2070

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  12 in total

1.  Time course and host responses to Escherichia coli urinary tract infection in genetically distinct mouse strains.

Authors:  W J Hopkins; A Gendron-Fitzpatrick; E Balish; D T Uehling
Journal:  Infect Immun       Date:  1998-06       Impact factor: 3.441

2.  In vivo dynamics of type 1 fimbria regulation in uropathogenic Escherichia coli during experimental urinary tract infection.

Authors:  N W Gunther; V Lockatell; D E Johnson; H L Mobley
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

3.  Development of a long-term ascending urinary tract infection mouse model for antibiotic treatment studies.

Authors:  H Hvidberg; C Struve; K A Krogfelt; N Christensen; S N Rasmussen; N Frimodt-Møller
Journal:  Antimicrob Agents Chemother       Date:  2000-01       Impact factor: 5.191

4.  Urothelial CD44 facilitates Escherichia coli infection of the murine urinary tract.

Authors:  Kasper M A Rouschop; Marc Sylva; Gwendoline J D Teske; Inge Hoedemaeker; Steven T Pals; Jan J Weening; Tom van der Poll; Sandrine Florquin
Journal:  J Immunol       Date:  2006-11-15       Impact factor: 5.422

5.  Antigen-specific responses accelerate bacterial clearance in the bladder.

Authors:  Praveen Thumbikat; Carl Waltenbaugh; Anthony J Schaeffer; David J Klumpp
Journal:  J Immunol       Date:  2006-03-01       Impact factor: 5.422

6.  A murine model of urinary tract infection.

Authors:  Chia-Suei Hung; Karen W Dodson; Scott J Hultgren
Journal:  Nat Protoc       Date:  2009-07-30       Impact factor: 13.491

7.  Contribution of mast cells to bacterial clearance and their proliferation during experimental cystitis induced by type 1 fimbriated E. coli.

Authors:  Rama Malaviya; Teruo Ikeda; Soman N Abraham; Ravi Malaviya
Journal:  Immunol Lett       Date:  2004-02-15       Impact factor: 3.685

8.  Induction of urinary tract infection by intraurethral inoculation with Escherichia coli: refining the murine model.

Authors:  W J Hopkins; J A Hall; B P Conway; D T Uehling
Journal:  J Infect Dis       Date:  1995-02       Impact factor: 5.226

9.  Cyclic AMP-regulated exocytosis of Escherichia coli from infected bladder epithelial cells.

Authors:  Brian L Bishop; Mathew J Duncan; Jeongmin Song; Guojie Li; David Zaas; Soman N Abraham
Journal:  Nat Med       Date:  2007-04-08       Impact factor: 53.440

10.  Relationship of type 1 pilus expression in Escherichia coli to ascending urinary tract infections in mice.

Authors:  A J Schaeffer; W R Schwan; S J Hultgren; J L Duncan
Journal:  Infect Immun       Date:  1987-02       Impact factor: 3.441

View more
  15 in total

Review 1.  Pathogenesis of Proteus mirabilis Infection.

Authors:  Chelsie E Armbruster; Harry L T Mobley; Melanie M Pearson
Journal:  EcoSal Plus       Date:  2018-02

2.  Recurrent Escherichia coli Urinary Tract Infection Triggered by Gardnerella vaginalis Bladder Exposure in Mice.

Authors:  Valerie P O'Brien; Matthew S Joens; Amanda L Lewis; Nicole M Gilbert
Journal:  J Vis Exp       Date:  2020-12-04       Impact factor: 1.355

3.  Simulating obstructive sleep apnea patients' oxygenation characteristics into a mouse model of cyclical intermittent hypoxia.

Authors:  Diane C Lim; Daniel C Brady; Pengse Po; Li Pang Chuang; Laise Marcondes; Emily Y Kim; Brendan T Keenan; Xiaofeng Guo; Greg Maislin; Raymond J Galante; Allan I Pack
Journal:  J Appl Physiol (1985)       Date:  2014-11-26

4.  Transurethral Instillation Procedure in Adult Male Mouse.

Authors:  Sanghee Lee; Alonso Carrasco; Randall B Meacham; Anna P Malykhina
Journal:  J Vis Exp       Date:  2017-11-02       Impact factor: 1.355

5.  Helminth-induced interleukin-4 abrogates invariant natural killer T cell activation-associated clearance of bacterial infection.

Authors:  Yi-Ju Hsieh; Chi-Ling Fu; Michael H Hsieh
Journal:  Infect Immun       Date:  2014-03-18       Impact factor: 3.441

6.  Expression and antimicrobial function of beta-defensin 1 in the lower urinary tract.

Authors:  Brian Becknell; John David Spencer; Ashley R Carpenter; Xi Chen; Aspinder Singh; Suzanne Ploeger; Jennifer Kline; Patrick Ellsworth; Birong Li; Ehrhardt Proksch; Andrew L Schwaderer; David S Hains; Sheryl S Justice; Kirk M McHugh
Journal:  PLoS One       Date:  2013-10-21       Impact factor: 3.240

7.  In vivo biodistribution and toxicity of intravesical administration of quantum dots for optical molecular imaging of bladder cancer.

Authors:  Ying Pan; Timothy Chang; Gautier Marcq; Changhao Liu; Bernhard Kiss; Robert Rouse; Kathleen E Mach; Zhen Cheng; Joseph C Liao
Journal:  Sci Rep       Date:  2017-08-24       Impact factor: 4.379

8.  Aggregating sequences that occur in many proteins constitute weak spots of bacterial proteostasis.

Authors:  Ladan Khodaparast; Laleh Khodaparast; Rodrigo Gallardo; Nikolaos N Louros; Emiel Michiels; Reshmi Ramakrishnan; Meine Ramakers; Filip Claes; Lydia Young; Mohammad Shahrooei; Hannah Wilkinson; Matyas Desager; Wubishet Mengistu Tadesse; K Peter R Nilsson; Per Hammarström; Abram Aertsen; Sebastien Carpentier; Johan Van Eldere; Frederic Rousseau; Joost Schymkowitz
Journal:  Nat Commun       Date:  2018-02-28       Impact factor: 14.919

9.  Evaluation of Recombinant Attenuated Salmonella Vaccine Strains for Broad Protection against Extraintestinal Pathogenic Escherichia coli.

Authors:  Jacob T Maddux; Zachary R Stromberg; Roy Curtiss Iii; Melha Mellata
Journal:  Front Immunol       Date:  2017-10-09       Impact factor: 7.561

10.  Escherichia coli Aggravates Calcium Oxalate Stone Formation via PPK1/Flagellin-Mediated Renal Oxidative Injury and Inflammation.

Authors:  Lingyue An; Weizhou Wu; Shujue Li; Yongchang Lai; Dong Chen; Zhican He; Zhenglin Chang; Peng Xu; Yapeng Huang; Min Lei; Zheng Jiang; Tao Zeng; Xinyuan Sun; Xuan Sun; Xiaolu Duan; Wenqi Wu
Journal:  Oxid Med Cell Longev       Date:  2021-07-13       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.